France begins trials of new COVID vaccine
Other countries
- 25 February, 2021
- 06:11
Add Report.az to preferred Google sources
Stay up to date with the top news!
French biotechnology company Xenothera has begun clinical trials of its coronavirus vaccine, Report informs with reference to TASS.
The vaccine is named Xav-19.
The vaccine testing program follows Polycor standards, one of 15 types of clinical trials of drugs approved by the French medical authorities. The trial will be carried out in 40 hospitals in the country, coordinated by the University Hospital of Nantes.
The drug will be tested on 400 volunteer patients. Currently, 67 patients from 21 hospitals are participating in the trial.
The tests are supposed to determine the level of vaccine effectiveness with great accuracy.
Fransada yeni koronavirus peyvəndinin sınaqlarına başlanılır
Во Франции начинаются испытания новой вакцины от COVID-19
Latest News
18:10
President Ilham Aliyev's social media accounts feature Lao leader's official visit
Foreign policy
18:07
Photo
Presidents of Azerbaijan and Laos deliver press statements - UPDATED
Foreign policy
17:51
Nakhchivan's foreign trade turnover up over 67%
Business
17:48
Ukrainian MP thanks Azerbaijani President for humanitarian aid
Other countries
17:44
Shavkat Mirziyoyev to arrive in Azerbaijan tomorrow
Foreign policy
17:44
Azerbaijani MPs voice concern over recent statements in Türkiye
Milli Majlis
17:39
ECO transport ministers to gather in Astana to approve long-term strategy
Infrastructure
17:34
US Embassy congratulates Azerbaijan's judokas on World Championship success
Individual sports
17:29
Azerbaijan's gasoline and diesel retail sales rise 4% in January-September
Energy